Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity
- 1 March 2002
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 52 (3), 599-605
- https://doi.org/10.1016/s0360-3016(01)02641-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the german prospective randomized trial hit ’91International Journal of Radiation Oncology*Biology*Physics, 2000
- Long-term hearing status after radiotherapy for nasopharyngeal carcinomaAuris Nasus Larynx, 1998
- Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Postirradiation sensorineural hearing loss: A common but ignored late radiation complicationInternational Journal of Radiation Oncology*Biology*Physics, 1996
- A prospective longitudinal study on radiation-induced hearing lossThe American Journal of Surgery, 1994
- Cis‐Platinum ototoxicity in childrenThe Laryngoscope, 1991
- Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation.Journal of Clinical Oncology, 1989
- Enhanced cis‐platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiationMedical and Pediatric Oncology, 1989
- Hearing loss in children receiving cisplatin chemotherapyThe Journal of Pediatrics, 1983